CIK: 0001674712 · Show all filings
Period: Q4 2018 (← Previous) (Next →)
Filing Date: Feb 13, 2019
Total Value ($000): $783,077 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma A/S | 2,166,832 | $135,752 | 17.3% | $26.35 | — | ADR | 04351P101 |
| CRNX | Crinetics Pharmaceuticals Inc | 3,792,169 | $113,727 | 14.5% | $29.69 | -5.2% | Common | 22663K107 |
| — | Biohaven Pharmaceutical Holding Company Ltd | 1,813,340 | $67,057 | 8.6% | $36.97 | — | Common | G11196105 |
| CDXS | Codexis, Inc | 2,714,458 | $45,331 | 5.8% | $3.85 | +347.8% | Common | 192005106 |
| SVA | Sinovac Biotech Ltd. | 5,900,000 | $40,946 | 5.2% | $7.22 | +1.2% | SHS | P8696W104 |
| ARWR | Arrowhead Pharmaceuticals Inc | 2,328,475 | $28,920 | 3.7% | $8.05 | +69.9% | Common | 04280A100 |
| KALV | KalVista Pharmaceuticals Inc. | 1,359,149 | $26,843 | 3.4% | $12.10 | +66.1% | Common | 483497103 |
| — | Homology Medicines, Inc. | 1,159,742 | $25,932 | 3.3% | $19.00 | — | Common | 438083107 |
| — | Kadmon Holdings Inc | 10,454,545 | $21,745 | 2.8% | $5.56 | — | Common | 48283N106 |
| — | Amyris, Inc | 5,575,785 | $18,623 | 2.4% | $5.54 | — | Common | 03236M200 |
| — | Tricida, Inc. | 781,185 | $18,413 | 2.4% | $29.90 | — | Common | 89610F101 |
| — | Eiger BioPharmaceuticals Inc | 1,791,257 | $18,199 | 2.3% | $16.42 | — | Common | 28249U105 |
| — | Menlo Therapeutics Inc. | 4,011,236 | $16,526 | 2.1% | $37.58 | — | Common | 586858102 |
| — | MEI Pharma Inc | 5,778,106 | $15,254 | 1.9% | $3.94 | — | Common | 55279B202 |
| IOVA | Iovance Biotherapeutics, Inc. | 1,600,000 | $14,160 | 1.8% | $9.64 | 0.0% | Common | 462260100 |
| — | Verona Pharma PLC | 1,492,951 | $13,437 | 1.7% | $13.61 | — | ADS | 925050106 |
| — | Orchard Therapeutics plc | 811,894 | $12,771 | 1.6% | $15.73 | — | ADS | 68570P101 |
| ACRS | Aclaris Therapeutics, Inc. | 1,647,214 | $12,173 | 1.6% | $19.11 | -46.1% | Common | 00461U105 |
| — | Obseva SA | 937,147 | $11,864 | 1.5% | $15.18 | — | Common | H5861P103 |
| — | Acer Therapeutics Inc | 579,051 | $11,651 | 1.5% | $30.59 | — | Common | 00444P108 |
| APLS | Apellis Pharmaceuticals, Inc. | 874,573 | $11,536 | 1.5% | $14.72 | +4.2% | Common | 03753U106 |
| — | Mirati Therapeutics Inc. | 251,107 | $10,652 | 1.4% | $42.42 | — | Common | 60468T105 |
| — | Nabriva Therapeutics AG | 6,619,190 | $9,664 | 1.2% | $6.08 | — | SHS | G63637105 |
| — | Zymeworks Inc | 620,134 | $9,104 | 1.2% | $14.78 | — | Common | 98985W102 |
| XENE | Xenon Pharmaceuticals Inc | 1,405,476 | $8,869 | 1.1% | $11.59 | -23.3% | Common | 98420N105 |
| AUPH | Aurinia Pharmaceuticals Inc. | 1,213,290 | $8,275 | 1.1% | $5.62 | +2.6% | Common | 05156V102 |
| — | Soleno Therapeutics, Inc. | 4,359,683 | $7,455 | 1.0% | $1.84 | — | Common | 834203200 |
| — | Kiniksa Pharmaceuticals | 264,878 | $7,440 | 1.0% | $19.77 | — | Common | G5269C101 |
| — | Cymabay Therapeutics Inc | 906,000 | $7,130 | 0.9% | $13.04 | — | Common | 23257D103 |
| — | Galmed Pharmaceuticals Ltd | 971,337 | $6,634 | 0.8% | $11.38 | — | SHS | M47238106 |
| — | Kala Pharmaceuticals, Inc. | 1,043,020 | $5,100 | 0.7% | $22.84 | — | Common | 483119103 |
| — | Zogenix, Inc. | 105,000 | $3,828 | 0.5% | $40.05 | — | Common | 98978L204 |
| — | Sierra Oncology, Inc | 2,438,270 | $3,219 | 0.4% | $1.55 | — | Common | 82640U107 |
| ARVN | Arvinas Holding Co LLC | 209,666 | $2,694 | 0.3% | $16.46 | -3.6% | Common | 04335A105 |
| — | Genocea Biosciences Inc | 8,180,000 | $2,346 | 0.3% | $1.05 | — | Common | 372427104 |
| ZLAB | Zai Lab Limited | 81,819 | $1,900 | 0.2% | $27.00 | — | ADR | 98887Q104 |
| — | BioPharmX Corporation | 16,128,515 | $1,740 | 0.2% | $0.36 | — | Common | 09072X101 |
| — | DBV Technologies S.A. | 269,995 | $1,733 | 0.2% | $6.42 | — | ADR | 23306J101 |
| — | Selecta Biosciences Inc | 546,054 | $1,453 | 0.2% | $19.86 | — | Common | 816212104 |
| — | Agile Therapeutics, Inc. | 1,513,975 | $872 | 0.1% | $6.21 | — | Common | 00847L100 |
| — | Trevena, Inc. | 1,728,000 | $743 | 0.1% | $7.67 | — | Common | 89532E109 |
| — | Foamix Pharmaceuticals Ltd. | 201,478 | $723 | 0.1% | $9.26 | — | SHS | M46135105 |
| — | Akari Therapeutics Plc | 345,850 | $543 | 0.1% | $14.00 | — | ADR | 00972G108 |
| — | Sunesis Pharmaceuticals, Inc. | 195,474 | $81 | 0.0% | $3.62 | — | Common PAR | 867328700 |
| — | Soleno Therapeutics, Inc. | 188,772 | $19 | 0.0% | $0.14 | — | Warrant | 834203135 |